Kate Bingham

Kate Bingham

Managing Partner, Therapeutics atSV Health InvestorsLondon

Kate Bingham co-leads SV's biotech franchise, investing in drug discovery and development companies. She was awarded a DBE in 2021 for chairing the UK Vaccine Taskforce.

What Kate can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. UK Vaccine Taskforce · Chair
    2021
  2. SV Health Investors · Managing Partner
    Now

Investments named in public bios

Affinium PharmaceuticalsAlantos PharmaceuticalsAuxilium PharmaceuticalsCognis HoldingConvergence PharmaceuticalsEUSA PharmaEyeBioGeltex PharmaceuticalsGenosisIncyte PharmaceuticalsKalVista PharmaceuticalsKinetix PharmaceuticalsKuDOS PharmaceuticalsLeica MicrosystemsLeukoSite IncMedNova

Focus

biotechdrug discoverydrug developmenttherapeutics

Education

University of Oxford, First class degree, BiochemistryHarvard Business School

Also at SV Health Investors

Partners like Kate

At firms with a similar stage, sector and check size.

Alert me when SV Health Investors is active

One email when Kate's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Kate Bingham?

Kate Bingham co-leads SV's biotech franchise, investing in drug discovery and development companies. She was awarded a DBE in 2021 for chairing the UK Vaccine Taskforce.

How much does Kate Bingham invest?

SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Kate Bingham?

A warm intro from a founder SV Health Investors backed works best.

What did Kate Bingham do before SV Health Investors?

Chair at UK Vaccine Taskforce.

Last updated 2026-10-15. Is this you? Ask for a correction.